tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Gliosis D005911 6 associated lipids
Kidney Tubular Necrosis, Acute D007683 3 associated lipids
Gingival Overgrowth D019214 7 associated lipids
Hallucinations D006212 4 associated lipids
Sleep Wake Disorders D012893 7 associated lipids
Rosacea D012393 13 associated lipids
Pericarditis D010493 6 associated lipids
Hyperpigmentation D017495 11 associated lipids
Autonomic Nervous System Diseases D001342 4 associated lipids
Psychoses, Substance-Induced D011605 7 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Long QT Syndrome D008133 10 associated lipids
Intestinal Pseudo-Obstruction D007418 5 associated lipids
Mycoses D009181 18 associated lipids
Liver Failure D017093 5 associated lipids
Epilepsy, Temporal Lobe D004833 4 associated lipids
Retinoblastoma D012175 12 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Gastroenteritis D005759 4 associated lipids
Hypertrophy, Left Ventricular D017379 12 associated lipids
Inappropriate ADH Syndrome D007177 4 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Lymphoma, T-Cell D016399 11 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Pityriasis D010915 3 associated lipids
Hand Dermatoses D006229 5 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Liver Abscess D008100 6 associated lipids
Carpal Tunnel Syndrome D002349 3 associated lipids
Foot Dermatoses D005533 3 associated lipids
Anus Diseases D001004 3 associated lipids
Endomyocardial Fibrosis D004719 4 associated lipids
Ataxia Telangiectasia D001260 6 associated lipids
Herpesviridae Infections D006566 4 associated lipids
Leukoencephalopathies D056784 3 associated lipids
Pouchitis D019449 3 associated lipids
Granuloma, Giant Cell D006101 7 associated lipids
Epstein-Barr Virus Infections D020031 3 associated lipids
Labyrinthitis D007762 2 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Dementia, Vascular D015140 7 associated lipids
Mastocytosis D008415 5 associated lipids
Molluscum Contagiosum D008976 2 associated lipids
Paresis D010291 2 associated lipids
Intracranial Hypertension D019586 4 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Chronic Disease D002908 7 associated lipids
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Vitiligo D014820 2 associated lipids
Hemophilia B D002836 3 associated lipids
Myasthenia Gravis D009157 5 associated lipids
Hyperkalemia D006947 3 associated lipids
Intracranial Thrombosis D020767 2 associated lipids
Pemphigus, Benign Familial D016506 3 associated lipids
Skin Diseases, Vesiculobullous D012872 5 associated lipids
Prurigo D011536 4 associated lipids
Hepatitis, Viral, Animal D006524 4 associated lipids
Cryptococcosis D003453 3 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Simian Acquired Immunodeficiency Syndrome D016097 4 associated lipids
Castleman Disease D005871 3 associated lipids
Wounds, Stab D014951 3 associated lipids
Keratosis, Actinic D055623 3 associated lipids
Toxocariasis D014120 3 associated lipids
Fistula D005402 8 associated lipids
Confusion D003221 4 associated lipids
Encephalitis, Viral D018792 3 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Optic Nerve Injuries D020221 4 associated lipids
Hyperuricemia D033461 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Viremia D014766 4 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Parotitis D010309 4 associated lipids
Tuberous Sclerosis D014402 2 associated lipids
Ocular Motility Disorders D015835 2 associated lipids
Pain, Intractable D010148 4 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Perceptual Disorders D010468 3 associated lipids
Polyneuropathies D011115 3 associated lipids
Heart Injuries D006335 6 associated lipids
Hearing Loss, Noise-Induced D006317 4 associated lipids
Exanthema D005076 11 associated lipids
Bronchiolitis D001988 6 associated lipids
Reflex Sympathetic Dystrophy D012019 4 associated lipids
Kartagener Syndrome D007619 2 associated lipids
Earache D004433 2 associated lipids
Delayed Graft Function D051799 2 associated lipids
Gingival Hyperplasia D005885 3 associated lipids
Intussusception D007443 1 associated lipids
Neoplasms, Second Primary D016609 4 associated lipids
Paraparesis, Tropical Spastic D015493 1 associated lipids
Crigler-Najjar Syndrome D003414 1 associated lipids
Apraxias D001072 1 associated lipids
Cholangitis, Sclerosing D015209 1 associated lipids
Venous Insufficiency D014689 2 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Huang K et al. [Prophylaxis and treatment of chronic graft versus host disease]. 2005 Zhonghua Er Ke Za Zhi pmid:15833186
Deng Z et al. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation]. 2014 Zhonghua Er Ke Za Zhi pmid:25224233
Zhou DJ and Wu XC [Meta-analysis of calcineurin inhibitor in the treatment of lupus nephritis]. 2011 Zhonghua Er Ke Za Zhi pmid:21624207
Wang ZL et al. [Management of pediatric patients who underwent liver transplantation]. 2007 Zhonghua Er Ke Za Zhi pmid:17880788
Wang HY et al. [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases]. 2012 Zhonghua Er Ke Za Zhi pmid:23302619
Nie F et al. [Post-transplant kidney from C-III donation after cardiac death of children: a clinicopathologic study of 20 cases]. 2016 Zhonghua Bing Li Xue Za Zhi pmid:26879429
Xie SP et al. [Study on the clinical application of wuzhi capsule after renal transplantation]. 2011 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:22013798
Ding CG et al. [Clinical application and exploration on mechanism of action of Cordyceps sinensis mycelia preparation for renal transplantation recipients]. 2009 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:20329604
Gu HY et al. [Significance of calcineurin activation and CD40L expression in patients with active lupus nephritis]. 2005 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21162213
Xie ZQ et al. [Antipruritic mechanisms of pimecrolimus cream for facial dermatitis in adult women patients]. 2009 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:19317053
Wen J et al. [Regulatory effects of cyclosporin A and tacrolimus on the immunological gene expressions in renal transplant recipients]. 2012 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:23286399
Tian T et al. [Effect of tacrolimus on the growth cycle of murine hair follicles]. 2007 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:17536270
Xie ZQ and Lan YZ Effectiveness of pimecrolimus cream for women patients with sensitive skin and its underlying mechanism. 2012 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:22954121
Chen GF et al. [Peripheral nerve regeneration under immunosuppression]. 2002 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:11944523
Xiong G et al. [Effects of immunosuppressants on proliferation of pheochromocytoma 12 and L929 cells]. 2007 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:17694665
Kang H et al. [Combined immunosuppression of FK506 and RS-61443 in rat limb allotransplantation]. 2003 Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi pmid:12822367
Yu HQ et al. [Study of tacrolimus intranasal treatment for allergic asthma in mice]. 2012 Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi pmid:23484272
Li Q et al. [Experimental study of electrophysiologic effects of regenerative nerve fibres affected by control releasing FK506]. 2010 Zhongguo Gu Shang pmid:21254678
Li Y et al. [Study on the Effect of Immunosuppressive Agent FK506 on Growth and Migration of Lung Cancer Cell]. 2017 Zhongguo Fei Ai Za Zhi pmid:28738959
Zhou Y et al. [Effect of tacrolimus on growth-associated protein-43 expression in the hippocampus of neonatal rats with hypoxic-ischemic brain damage]. 2009 Zhongguo Dang Dai Er Ke Za Zhi pmid:19149927
Huang WY [Clinical application and side effects of immunosuppressant]. 2007 Zhongguo Dang Dai Er Ke Za Zhi pmid:17448303
Sun Y et al. [Total glucosides of peony as adjuvant therapy for prevention of cardiac allograft rejection in rats]. 2007 Zhong Xi Yi Jie He Xue Bao pmid:17854565
Li Y et al. [Effects of tacrolimus and cyclosporine on albumin secretion in cultured human hepatocyte]. 2006 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:16859130
Peng LK et al. [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus]. 2007 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:17344588
Li D et al. [Effect of genetic polymorphism on disposition of calcineurin inhibitors in solid organ transplantation]. 2010 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:20871172
Chiu MC Management strategy for idiopathic nehprotic syndrome in children. 2008 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:18245896
Liu Y and Zheng M [Suppression of Tacrolimus on the expression of MMP-9 in rhHGF-stimulated ECV304 cell line]. 2004 Zhejiang Da Xue Xue Bao Yi Xue Ban pmid:15586415
David M et al. [Changes in cervix cytology in women with liver transplants treated with immunosuppressive therapy]. 1993 Zentralbl Gynakol pmid:7692689
Lütkes P et al. [Quality of life following transplantation. The impact ofa new immunosuppressive substance]. 1999 Zentralbl Chir pmid:10209841
Weiner SM [Combination of tacrolimus and MMF for treatment of proliferative lupus nephritis]. 2016 Z Rheumatol pmid:27259912
Grube E et al. Drug eluting stents: initial experiences. 2002 Z Kardiol pmid:12641014
Scheller B et al. Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model. 2005 Z Kardiol pmid:15997345
König A et al. Intravascular ultrasound for assessment of coronary allograft vasculopathy. 2000 Z Kardiol pmid:11151792
Ocran KW et al. Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation. 1999 Z Gastroenterol pmid:10549098
Müller MK et al. [Pathophysiologic concepts and protective possibilities in experimental pancreatic lesions]. 1993 Z Gastroenterol pmid:7504856
Petrides AS [Do immunosuppressive agents really impair glucose tolerance in liver transplant patients?]. 1995 Z Gastroenterol pmid:7571761
Arnold JC and Theilmann L [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. 1995 Z Gastroenterol pmid:7502559
Buechter M et al. Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis. 2014 Z Gastroenterol pmid:24905108
Kanzler S et al. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A. 1996 Z Gastroenterol pmid:8659188
Schwarz A [Drug-induced kidney damage]. 1996 Z Arztl Fortbild (Jena) pmid:8779233
Oh CK et al. Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation. 2014 Yonsei Med. J. pmid:25048494
Lee JH et al. Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea. 2009 Yonsei Med. J. pmid:20046418
First MR and Fitzsimmons WE Modified release tacrolimus. 2004 Yonsei Med. J. pmid:15627307
Partaledis JA et al. Saccharomyces cerevisiae contains a homolog of human FKBP-13, a membrane-associated FK506/rapamycin binding protein. 1992 Yeast pmid:1279908
Zhang GM et al. [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients]. 2008 Yao Xue Xue Bao pmid:18819472
Deng CH et al. [The therapeutic drug monitoring network server of tacrolimus for Chinese renal transplant patients]. 2011 Yao Xue Xue Bao pmid:22010353
Guan Z et al. [Application of Fourier amplitude sensitivity test in Chinese healthy volunteer population pharmacokinetic model of tacrolimus]. 2010 Yao Xue Xue Bao pmid:20931787
Zhang YJ et al. [Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target]. 2006 Yao Xue Xue Bao pmid:17184105
Zhu L et al. [Effect of CYP3A4*18B, CYP3A5*3 gene polymorphism on dosage and concentration of tacrolimus in renal transplant patients]. 2012 Yao Xue Xue Bao pmid:22993851
Fu XH et al. [Prediction of blood tacrolimus concentration in liver transplantation recipients by artificial neural network]. 2012 Yao Xue Xue Bao pmid:23227541